Fortis Advisors’s DexCom DXCM Stock Holding History

Fortis Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,352	Closed	-$158K	–	213
2020 Q1	$158K	Buy	+2,352	New	+$146K	0.11%	104
2019 Q1	–	Sell	-5,392	Closed	-$161K	–	321
2018 Q4	$161K	Buy	+5,392	New	+$171K	0.1%	123

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fortis Advisors's DXCM Position: Q2 2020 in Review

Fortis Advisors sold out of DexCom (DXCM) in Q2 2020, closing a stake of 2,352 shares — an estimated $158K sold.

Fortis Advisors first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $161K in Q4 2018. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

Fortis Advisors reported no remaining DexCom position as of Q2 2020 after selling out during the quarter.
Fortis Advisors sold 2,352 DexCom shares in Q2 2020, an estimated $158K.
Fortis Advisors first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
Fortis Advisors's DexCom position peaked at $161K in Q4 2018.
723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.